Erasmus University Medical Center Rotterdam is committed to a healthy population and excellence in healthcare through research and education. The centre has broad expertise in various research fields, ranging from fundamental and clinical domains to public health and prevention. Erasmus MC holds over 80 projects funded by the European Commission, of which 70 Horizon 2020 projects including collaborations with partners from 56 countries worldwide. Bibliometric indicators place Erasmus MC in the top 20 of clinical medicine worldwide. In addition to scientific research, patient care and education are core tasks of Erasmus MC. It is the top referral centre for a region of about five million inhabitants.
The Department of Gastroenterology and Hepatology houses a large inflammatory bowel disease (IBD) outpatient clinic with about 350 new patients with IBD each year and in total 2500 outpatients.
Main tasks in the project
EMC is the clinical leader for inflammatory bowel disease and will participate in the IBD clinical study in WP2 and WP6.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853981. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and PARKINSON’S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.